🇺🇸 FDA
Patent

US 7056509

Antibody methods for selectively inhibiting VEGF

granted A61KA61K2039/505A61K39/3955

Quick answer

US patent 7056509 (Antibody methods for selectively inhibiting VEGF) held by The Board of Regents of the University of Texas System expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/505, A61K39/3955, A61K47/6811, A61K47/6815